RBC Capital Starts Prometheus Biosciences Inc (RXDX) at Outperform
Tweet
Share
E-mailGet Alerts RXDX Hot Sheet
Price: $199.92 --0%
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 11
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 11
Join SI Premium – FREE
RBC Capital analyst Gregory Renza initiates coverage on Prometheus Biosciences Inc (NASDAQ: RXDX) with a Outperform rating and a price target of $46.00.
For an analyst ratings summary and ratings history on Prometheus Biosciences Inc click here. For more ratings news on Prometheus Biosciences Inc click here.
Shares of Prometheus Biosciences Inc closed at $33.38 yesterday.
You May Also Be Interested In
- BofA Securities Reinstates Zoom Video (ZM) at Buy
- Goldman Sachs Assumes Cosair Gaming (CRSR) at Sell
- Wolfe Research Starts AFLAC (AFL) at Underperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
